News

PASADENA, Calif.   – Expanding blood pressure screenings to non-primary care settings can help identify more patients with high blood pressure, commonly called  hypertension, and could contribute to better hypertension control and management, according to a Kaiser Permanente study published today in The Journal of Clinical Hypertension. Researchers examined the electronic health records of 1,076,000 Kaiser Permanente ...

PASADENA, Calif.,  – A comprehensive, population-based regional health care management program for men with prostate cancer who are members of Kaiser Permanente Southern California has led to improved outcomes, according to a Kaiser Permanente study published today in the journal Urology Practice. While prostate cancer is the second-leading cause of cancer death among men, providing high ...

Progression and Treatment of Lower Urinary Tract Symptoms

PASADENA, Calif. – Self-reported moderate to vigorous exercise was associated with lower blood pressure and blood glucose levels in a Kaiser Permanente study published in the journal Preventing Chronic Disease. Data collected from Kaiser Permanente’s Exercise as a Vital Sign (EVS) program, in which medical office staff asks patients about their exercise habits at every ...

PASADENA, Calif.  – The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes. The study included data from more than 2 million children and adolescents living in diverse geographic regions of ...

PASADENA, Calif.  – The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases. Researchers examined the electronic health records of more than 21,000 Kaiser Permanente patients in Southern California who were 60 years ...

PASADENA, Calif. – The mantra for treatment for high blood pressure has been the lower, the better, but that goal can potentially put patients at risk of kidney failure or death, according to a Kaiser Permanente study published today in the Journal of the American College of Cardiology.  Researchers examined the electronic health records of nearly ...

OAKLAND, Calif.  – A new 5-year, $7.3 million award from the National Cancer Institute will allow Kaiser Permanente to expand its innovative cancer clinical trials program.   The award, part of the NCI Community Oncology Research Program (NCORP), will help Kaiser Permanente focus on enrolling patients in the NCI National Clinical Trials Network, testing cutting-edge therapies, and ...